sunitinib mylan 37,5 mg
mylan ireland limited, Írsko - sunitinib - 44 - cytostatica
sunitinib mylan 25 mg
mylan ireland limited, Írsko - sunitinib - 44 - cytostatica
sunitinib mylan 12,5 mg
mylan ireland limited, Írsko - sunitinib - 44 - cytostatica
posakonazol mylan 40 mg/ml
mylan ireland limited, Írsko - posakonazol - 26 - antimycotica (lokÁlne a celkovÉ)
dasatinib mylan 100 mg
mylan ireland limited, Írsko - dasatinib - 44 - cytostatica
dasatinib mylan 70 mg
mylan ireland limited, Írsko - dasatinib - 44 - cytostatica
dexmedetomidine mylan 100 mikrogramov/ml
mylan ireland limited, Írsko - dexmedetomidín - 57 - hypnotica, sedativa
fingolimod mylan
mylan ireland limited - fingolimod hydrochlorid - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older:patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 a 5. 1)orpatients s rýchlo sa meniacim ťažké recidivujúce odosielajúcej roztrúsená skleróza definovaná 2 alebo viac vypnutie relapsami v jednom roku, a s 1 alebo viac gadolínium zvýšenie lézie v mozgu mri alebo významný nárast v t2 lézií zaťažení v porovnaní s predchádzajúcim posledných mri.
fingolimod mylan
mylan ireland limited - fingolimod hydrochlorid - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 a 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.
memantin mylan 10 mg/ml perorálny roztok
mylan ireland limited, Írsko - memantín - 06 - psychostimulantia (nootropne lieČ., analeptika)